+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Somatostatin Analogs Market Intelligence Report - Global Forecast to 2027

  • PDF Icon

    Report

  • 119 Pages
  • July 2022
  • Region: Global
  • Think Market Intelligence
  • ID: 5624263
UP TO OFF until Dec 31st 2022
The Global Somatostatin Analogs Market is projected to reach USD 10,060.51 million by 2027 from USD 5,608.29 million in 2021, at a CAGR of 10.22% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

  • The Americas Somatostatin Analogs Market size was estimated at USD 1,721.50 million in 2021 and expected to reach USD 1,902.95 million in 2022, at a CAGR of 10.38% to reach USD 3,115.11 million by 2027.
  • The Asia-Pacific Somatostatin Analogs Market size was estimated at USD 1,455.58 million in 2021 and expected to reach USD 1,607.02 million in 2022, at a CAGR of 10.34% to reach USD 2,627.54 million by 2027.
  • The Europe, Middle East & Africa Somatostatin Analogs Market size was estimated at USD 2,431.20 million in 2021 and expected to reach USD 2,662.07 million in 2022, at a CAGR of 10.04% to reach USD 4,317.85 million by 2027.

Market Segmentation & Coverage:

The report on somatostatin analogs identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the somatostatin analogs to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

  • Lanreotide
  • Octreotide
  • Pasireotide

Application:

  • Acromegaly
  • Neuroendocrine Tumors

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Colorado
      • Florida
      • Illinois
      • Minnesota
      • New York
      • North Carolina
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
  • Europe, Middle East & Africa
    • France
    • Germany
    • Italy
    • Netherlands
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • Amryt Pharma plc
  • Camurus AB
  • Crinetics Pharmaceuticals, Inc.
  • CVS Health Corporation
  • Dauntless Pharmaceuticals, Inc.
  • Fresenius SE & Co. KGaA
  • Hybio Pharmaceutical Co., Ltd.
  • Ipsen Pharma
  • Merck KGaA
  • Midatech Pharma PLC
  • Novartis International AG
  • Peptron, Inc.
  • Pfizer Inc.
  • Recordati Rare Diseases, Inc.
  • Sun Pharmaceutical Industries Limited
  • Teijin Limited
  • Teva Pharmaceuticals Inc.
  • Viatris Inc.
Frequently Asked Questions about the Global Somatostatin Analogs Market

What is the estimated value of the Global Somatostatin Analogs Market?

The Global Somatostatin Analogs Market was estimated to be valued at $5608.29 Million in 2021.

What is the growth rate of the Global Somatostatin Analogs Market?

The growth rate of the Global Somatostatin Analogs Market is 10.2%, with an estimated value of $10060.51 Million by 2027.

What is the forecasted size of the Global Somatostatin Analogs Market?

The Global Somatostatin Analogs Market is estimated to be worth $10060.51 Million by 2027.

Who are the key companies in the Global Somatostatin Analogs Market?

Key companies in the Global Somatostatin Analogs Market include Amryt Pharma plc, Camurus AB, Crinetics Pharmaceuticals, Inc., CVS Health Corporation, Dauntless Pharmaceuticals, Inc., Fresenius SE & Co. KGaA, Hybio Pharmaceutical Co., Ltd., Ipsen Pharma and Midatech Pharma PLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Market Overview
4. Somatostatin Analogs Market, by Type
4.1. Introduction
4.2. Lanreotide
4.3. Octreotide
4.4. Pasireotide
5. Somatostatin Analogs Market, by Application
5.1. Introduction
5.2. Acromegaly
5.3. Neuroendocrine Tumors
6. Company Usability Profiles
6.1. Amryt Pharma plc
6.2. Camurus AB
6.3. Crinetics Pharmaceuticals, Inc.
6.4. CVS Health Corporation
6.5. Dauntless Pharmaceuticals, Inc.
6.6. Fresenius SE & Co. KGaA
6.7. Hybio Pharmaceutical Co., Ltd.
6.8. Ipsen Pharma
6.9. Merck KGaA
6.10. Midatech Pharma PLC
6.11. Novartis International AG
6.12. Peptron, Inc.
6.13. Pfizer Inc.
6.14. Recordati Rare Diseases, Inc.
6.15. Sun Pharmaceutical Industries Limited
6.16. Teijin Limited
6.17. Teva Pharmaceuticals Inc.
6.18. Viatris Inc.
7. Appendix
7.1. Discussion Guide
7.2. License & Pricing
List of Figures
Figure 1. Global Somatostatin Analogs Market: Research Process
Figure 2. Global Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 3. Global Somatostatin Analogs Market Size, by Region, 2021 Vs 2027 (%)
Figure 4. Global Somatostatin Analogs Market Size, by Region, 2021 Vs 2027 (USD Million)
Figure 5. Global Somatostatin Analogs Market Competitive Strategic Window, by Region, 2027
Figure 6. Global Somatostatin Analogs Market Size, by Country, 2021 Vs 2027 (%)
Figure 7. Global Somatostatin Analogs Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 8. Global Somatostatin Analogs Market Competitive Strategic Window, by Country, 2027
Figure 9. Global Somatostatin Analogs Market Size, by Type, 2021 Vs 2027 (%)
Figure 10. Global Somatostatin Analogs Market Size, by Type, 2021 Vs 2027 (USD Million)
Figure 11. Global Somatostatin Analogs Market Competitive Strategic Window, by Type, 2027
Figure 12. Global Somatostatin Analogs Market Size, by Lanreotide, 2019-2027 (USD Million)
Figure 13. Global Somatostatin Analogs Market Size, by Octreotide, 2019-2027 (USD Million)
Figure 14. Global Somatostatin Analogs Market Size, by Pasireotide, 2019-2027 (USD Million)
Figure 15. Global Somatostatin Analogs Market Size, by Application, 2021 Vs 2027 (%)
Figure 16. Global Somatostatin Analogs Market Size, by Application, 2021 Vs 2027 (USD Million)
Figure 17. Global Somatostatin Analogs Market Competitive Strategic Window, by Application, 2027
Figure 18. Global Somatostatin Analogs Market Size, by Acromegaly, 2019-2027 (USD Million)
Figure 19. Global Somatostatin Analogs Market Size, by Neuroendocrine Tumors, 2019-2027 (USD Million)
List of Tables
Table 1. Global Somatostatin Analogs Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2019-2021
Table 3. Global Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 4. Global Somatostatin Analogs Market Size, by Region, 2019-2027 (USD Million)
Table 5. Global Somatostatin Analogs Market Size, by Country, 2019-2027 (USD Million)
Table 6. Global Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 7. Global Somatostatin Analogs Market Size, by Lanreotide, 2019-2027 (USD Million)
Table 8. Global Somatostatin Analogs Market Size, by Lanreotide, by Region, 2019-2027 (USD Million)
Table 9. Global Somatostatin Analogs Market Size, by Lanreotide, by Region, 2019-2027 (USD Million)
Table 10. Global Somatostatin Analogs Market Size, by Octreotide, 2019-2027 (USD Million)
Table 11. Global Somatostatin Analogs Market Size, by Octreotide, by Region, 2019-2027 (USD Million)
Table 12. Global Somatostatin Analogs Market Size, by Octreotide, by Region, 2019-2027 (USD Million)
Table 13. Global Somatostatin Analogs Market Size, by Pasireotide, 2019-2027 (USD Million)
Table 14. Global Somatostatin Analogs Market Size, by Pasireotide, by Region, 2019-2027 (USD Million)
Table 15. Global Somatostatin Analogs Market Size, by Pasireotide, by Region, 2019-2027 (USD Million)
Table 16. Global Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 17. Global Somatostatin Analogs Market Size, by Acromegaly, 2019-2027 (USD Million)
Table 18. Global Somatostatin Analogs Market Size, by Acromegaly, by Region, 2019-2027 (USD Million)
Table 19. Global Somatostatin Analogs Market Size, by Acromegaly, by Region, 2019-2027 (USD Million)
Table 20. Global Somatostatin Analogs Market Size, by Neuroendocrine Tumors, 2019-2027 (USD Million)
Table 21. Global Somatostatin Analogs Market Size, by Neuroendocrine Tumors, by Region, 2019-2027 (USD Million)
Table 22. Global Somatostatin Analogs Market Size, by Neuroendocrine Tumors, by Region, 2019-2027 (USD Million)
Table 23. Global Somatostatin Analogs Market: License & Pricing

Companies Mentioned

  • Amryt Pharma plc
  • Camurus AB
  • Crinetics Pharmaceuticals, Inc.
  • CVS Health Corporation
  • Dauntless Pharmaceuticals, Inc.
  • Fresenius SE & Co. KGaA
  • Hybio Pharmaceutical Co., Ltd.
  • Ipsen Pharma
  • Merck KGaA
  • Midatech Pharma PLC
  • Novartis International AG
  • Peptron, Inc.
  • Pfizer Inc.
  • Recordati Rare Diseases, Inc.
  • Sun Pharmaceutical Industries Limited
  • Teijin Limited
  • Teva Pharmaceuticals Inc.
  • Viatris Inc.

Methodology

Loading
LOADING...